Search
for

    Sort by

    Research 781–810 of 1000+

    1. Potency of a novel saw palmetto ethanol extract, SPET-085, for inhibition of 5α-reductase II Advances in Therapy · 2010 · 46 citations
    2. Effects of Finasteride on Vascular Endothelial Growth Factor Scandinavian Journal of Urology and Nephrology · 2002 · 35 citations
    3. Maximum Efficacy of Finasteride Is Obtained within 6 Months and Maintained over 6 Years European Urology · 1998 · 34 citations
    4. Cyproterone Acetate in the Treatment of Sexual Disorders: Pharmacological Base and Clinical Experience Experimental and clinical endocrinology & diabetes · 2009 · 30 citations
    5. Clinical applications of antiandrogens Journal of Steroid Biochemistry · 1988 · 29 citations
    6. New ester derivatives of dehydroepiandrosterone as 5α-reductase inhibitors Steroids · 2011 · 14 citations
    7. Biomarker-based methods for determining noncompliance in a prevention trial Controlled Clinical Trials · 2002 · 11 citations
    8. Finasteride Expert Opinion on Drug Metabolism & Toxicology · 2010 · 10 citations
    9. Frontal fibrosing alopecia after antiandrogen hormonal therapy in a male patient Journal of the European Academy of Dermatology and Venereology · 2018 · 9 citations
    10. Finasteride treatment and neuroactive steroid formation. PubMed · 2009 · 9 citations
    11. New Aromatic Esters of Progesterone as Antiandrogens Journal of Enzyme Inhibition and Medicinal Chemistry · 2004 · 6 citations
    12. 5alpha-reductase inhibitors/finasteride. PubMed · 1996 · 4 citations
    13. Biochemical and Histopathological evaluation of prostatic tissue under effect of Pterostilbene in benign prostatic hyperplasia rat model Al Mustansiriyah Journal of Pharmaceutical Sciences · 2023 · 2 citations
    14. IsoPSA Performance Characteristics are Unaffected by 5-Alpha Reductase Inhibitors or Alpha-Blockers: Results From the IsoPSA Validation Study Urology · 2023 · 2 citations
    15. Finasteride Springer eBooks · 2011 · 2 citations
    16. Zhuangyao Jianshen pill ameliorates testosterone-induced benign postatic hyperplasia in rats. PubMed · 2024 · 1 citations
    17. Adherence with protocol medication use and mortality from unrelated causes in a prevention trial Preventive Medicine · 2021 · 1 citations
    18. Editorial Comment The Journal of Urology · 2009 · 1 citations
    19. A Guideline for Discussion and Some Thoughts The Journal of Urology · 2009 · 1 citations
    20. Louisiana Marinas and Boat Launches, LOSCO (2003) [marinas] Urologia Internationalis · 2003 · 1 citations
    21. Low-dose finasteride in benign prostatic hyperplasia: a comprehensive narrative review of efficacy, safety, and preventative potential Translational Andrology and Urology · 2026
    22. Androgen receptor signaling as a new target for intervention in acute myeloid leukemia Blood Advances · 2025
    23. Efeitos de diferentes doses do Minoxidil oral, em dois tempos de exposição, no complexo prostático de camundongos Balb/C 2024
    24. Επικύρωση της χρησιμότητας των νεότερων παραμέτρων του PSA ορού για την ανίχνευση του καρκίνου του προστάτη 2018
    25. Finasteride Doesn't Shorten Survival in Long-term Study Cancer Discovery · 2013
    26. 1747 PREDICTION OF BLADDER PROSTATIC OBSTRUCTION: DEVELOPMENT OF A SIMPLIFIED CLINICAL NOMOGRAM The Journal of Urology · 2013
    27. The role of multicultural festivals in a society in transition: From being ethnically homogeneous to becoming multicultural 2012
    28. Prostatakarzinom Der Urologe · 2011
    29. 309 DOES VARIATION IN EITHER AGE AT START OF THERAPY OR DURATION OF THERAPY MAKE CHEMOPREVENTION WITH FINASTERIDE COST-EFFECTIVE? The Journal of Urology · 2011
    30. 황백(黃柏)이 전립선비대증(前立腺肥大症) Rat에 미치는 영향 Journal of Oriental Medicine · 2010